Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® long-term treatment of growth hormone deficiency in adults.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S

Criteria

Inclusion Criteria:

• Severe adult growth hormone deficiency

Exclusion Criteria:

• Known or suspected allergy to study product(s) or related products

• Previous participation in the study

• Diabetes Mellitus

• Presence of malignant tumor(s)

• Pregnant or likely to get pregnant